Optimization of the Surgical Care Pathway for Kidney Tumors by Digitizing Perioperative Nursing Coordination (UroCCR 126)
NCT ID: NCT06047600
Last Updated: 2025-06-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
1307 participants
INTERVENTIONAL
2023-10-23
2026-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Salvage Radiotherapy After Radical Prostatectomy
NCT02597725
Advantage of a Fast-recovery Protocol for Minimally Invasive Kidney Surgery
NCT04601129
Day-case Endourology; Patient Experience
NCT06152679
Comprehensive Geriatric Assessment for Perioperative Optimization in Cystectomy
NCT05679557
Partial Nephrectomy in Low Pressure
NCT05404685
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The objective is to deploy a model for coordinating the perioperative care pathway of patients who have undergone nephrectomy for renal tumor in several French centers in order to assess the impact for patients, caregivers and the health system.
This coordination would lead to the formalization of a nurse coordinator job profile adapted to the specificities of oncological surgery and the tools necessary for its implementation. The UroConnect device has a "patient" interface for presenting self-questionnaires and access to a library of educational content and a "caregiver" interface to rationalize and optimize the nurse's activity of perioperative coordination in his task.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SEQUENTIAL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control Group
The control group is based on the pre-existing organization, with no digital patient follow-up tools.
No interventions assigned to this group
Uroconnect Follow Up Group
The UroConnect device has a "patient" interface for presenting self-questionnaires and access to a library of educational content and a "caregiver" interface to rationalize and optimize the nurse's activity of perioperative coordination in his task
Uroconnect Follow Up Group
Inplementation of UroConnect remote monitoring Medical Device (DM) to optimize patient support and nursing coordination.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Uroconnect Follow Up Group
Inplementation of UroConnect remote monitoring Medical Device (DM) to optimize patient support and nursing coordination.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Affiliation or beneficiary of the French social security
* Expressed consent for integration of the UroCCR cohort,
* Expressed consent to participate in the DiPRU study.
Exclusion Criteria
* Participant under guardianship or curatorship
* Pregnancy at the time of surgery
* No internet access
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Bordeaux
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU d'Angers
Angers, , France
CHU de Bordeaux
Bordeaux, , France
Centre Catalan d'Urologie
Cabestany, , France
CHU de Caen
Caen, , France
Hôpital Henri Mondor
Créteil, , France
APHM
Marseille, , France
CH de Mont de Marsan
Mont-de-Marsan, , France
CHU de Nantes
Nantes, , France
CHU de Nîmes
Nîmes, , France
CHU de Strasbourg
Strasbourg, , France
CHu de Toulouse
Toulouse, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Thibaut Waeckel, Dr
Role: primary
De VERGIE Stéphane, Dr
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CHUBX2022/77
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.